WO1985005638A1 - Enzyme hydrazides - Google Patents
Enzyme hydrazides Download PDFInfo
- Publication number
- WO1985005638A1 WO1985005638A1 PCT/US1985/000992 US8500992W WO8505638A1 WO 1985005638 A1 WO1985005638 A1 WO 1985005638A1 US 8500992 W US8500992 W US 8500992W WO 8505638 A1 WO8505638 A1 WO 8505638A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- enzyme
- hydrazide
- enz
- glycoconjugates
- linked
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
- G01N33/561—Immunoelectrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Definitions
- hydrazido derivatives of enzymes for the selective staining or laoeling of various macromolecular species.
- Procedures involving the use of such enzyme hy ⁇ razides may be rendere ⁇ specific chemically for proteins, glycoconjugates, sialoglycoconjugates, galactoglycoconjugates, nucleic acids, as well as naturally existing or chemically introduced carDonydrate-containing, aldehyde-containing, amino-containing, and carboxyl-containing macromolecules.
- target compounds may be attached to solid supports, e.g. membrane filters, microtiter plates or intact cells, and the described procedures may be used for the detection, localization and quantification of the desired target compound.
- the ⁇ etection, localization, identification ana assay of biologically active macromolecules are achieve ⁇ by a variety of analytical methods.
- the latter are usually accomplished by a comoination of physical-chemical separation together witn selective staining or labeling procedures.
- a complex mixture of proteins can be separated according to size by polyacrylamide gel electrophoresis in the presence of sodium dodecyl suifate (SUS-PAGE) or according to charge by isoiectric focusing (IEF), and the pattern of the individual protein bands can oe visualized oy a general stain for proteins, e.g. Coomassie Brilliant Blue or Amido Black.
- Alixatively radiolaoled proteins may be visualized on gels by autoradiograpny.
- Nucleic acids resolved in agarose or in polyacrylamide gels, can be detected with Coomassie Brilliant Blue or via interaction with the fluorescent dye ethidium bromide.
- Sugar-containing proteins (glycoproteins) and other sugar-containing macromolecules e.g. glycolipids, mucopolysaccharides, lipopoly-saccharides, peptidoglycans, and simple homo- or heteropolysaccharides, can also be visualized by various techniques.
- the resultant aldehydes can then be labeled specifically by chemical means.
- oxidized sugars can be labeled by radioactive reagents (e.g., tritiated sodium borohydride) and the latter can be visualized by autoradiography or radiofluorography.
- radioactive reagents e.g., tritiated sodium borohydride
- This procedure has many inherent advantages, including (a) increased facility in handling, (b) improved accessibility of immobilized macromolecules to various reagents, (c) reduction in sample size, (d) reduction in processing time, (e) possibility for producing multiple replicas of single gels, (f) transferred patterns can be stored for long periods of time, (g) a single pattern can be subjected to multiple successive analyses, and (h) blots are amenable to analytical procedures impracticable on gels.
- Enzyme hydrazides can be prepared in numerous ways. Several representative examples will oe described herein. Essentially, functional hydrazide residues or polymeric forms of hydrazides can be linked to a functional enzyme either (a) directly by chemical (covalent) means, (b) bridged via a functionally inert spacer, or (c) bridged via an intermediate functional molecules(s), e.g. via the avidin-biotin complex or via an antibody directed toward the enzyme.
- a functional enzyme either (a) directly by chemical (covalent) means, (b) bridged via a functionally inert spacer, or (c) bridged via an intermediate functional molecules(s), e.g. via the avidin-biotin complex or via an antibody directed toward the enzyme.
- Hydrazides can be covalently linked to glutamate, aspartate and
- dihyorazides e.g. maleic, succinic or adipic dihydrazide
- the enzyme can be reacted successively with an excess of dialdehyde (e.g. glutaraldehyde) followed by an excess of dihydrazide (i.e. maleic, succinic, adipic, etc.):
- dialdehyde e.g. glutaraldehyde
- dihydrazide i.e. maleic, succinic, adipic, etc.
- Further stabilization of the hydrazone groupsformed can be accomplished by their reduction (e.g. using oorohydride, cyanoborohydride, etc.).
- Hydrazide derivatives of glycoprotein enzymes or enzymes which have been glycosylated through chemical or enzymatic (or biological) means can be prepared by prior activation of the resident sugars by periodate.
- enzymatic treatment either by galactose oxidase alone or by combined neuraminidase/ galactose oxidase, will generate aldehydes on appropriate glycoproteins.
- the activated glycoprotein can then be incubated with a suitable dihydrazide thereby producing the enzyme hydrazide via endogenous carbohydrates.
- the extent of hydrazidation of a given enzyme can be increased by first succinylating the resident amino groups of the enzyme followed by direct hydrazidation of both the endogenous (y) as well as the succinyl-derived (x) carboxyls on the modified enzyme.
- a soluole polyhydrazide e.g. polyacrylic hydrazide, polysialic acio hydrazide, or polyglutamic hyorazide
- WSC glutaraldehyde
- carboxyl containing polymers e.g. polyglutamic acid
- hydrazidation of the conjugate can then be performed.
- Hydrazidation of an antibody which recognizes the enzyme can first oe performed and the antioody-hy ⁇ razioe can be reacted with the target molecule. Suoseouently, the antiocoy-bound target molecule can be incubated with the unmodified enzyme. Alternatively, premade soluble complexes consisting of the enzyme and antibody-hydrazide can oe prepared and these complexes can be interacted with the target molecule.
- Avidin-biotin technology can also serve as an appropriate intermediate.
- the enzyme can oe oiotinylate ⁇ un ⁇ er mild conditions which do not significantly affect enzyme activity (E.A. Bayer and M.
- avidin-hydrazide can be prepared by one of the above-described methods. The avidin-hydrazide can then oe used to chemically label the target molecule via the hyorazide moiety. Suose ⁇ uent interaction with tne biotinylated enzyme serves to associate the enzyme ana target molecules via the avidin-biotin complex. Similar to antibody mediation, premade hydrazido-avioin/biotinylated enzyme complexes can be used to label the target molecule.
- any enzyme can oe used for the preparation of the new reagent, the only constraint being that the process of adding the hydrazide functional group does not inactivate or interfere significantly with the enzyme activity.
- hydrazide moieties may be introduced via many functional groups, e.g. via amino, carooxyl, aldehyoo or sulfhydryl groups, etc., of the protein, one would expect tnat a gentle permissible protocol for each possible enzyme to be modified could be developed.
- the enzyme hydrazide is to oe used for localization purposes via histochemical technioues, the product ootained snoulo be insoluble in a ⁇ ueous solutions ano of a high contrast color.
- Numerous protocols of this type have been developed for a plethora of enzymes. References to a few examples are nerewith provided: (2a) Alkaline phosphatase; M.S. Burstone (1962) Enzyme Histochemistry and Its application in the study of Neoplasm. Academic Press,
- Quantitative detection of enzyme hydrazide conjugates is possible by reacting the enzyme with a substrate that renders a soluble product that can be quantified spectrophotometrically.
- o-phenyldiamine could be used for detection of horseradish peroxidase or p-nitrophenol phosphate for alkaline phosphatase or o-nitrophenyl galactoside with ⁇ -galactosidase, etc.
- Another alternative which can provide quantitative detection is to solubilize the precipitated enzyme product in an organic solvent which can then be quantified spectrophotometrically.
- the fast red product generated in the alkaline phosphatase reaction with napthol- AS-MX phosphate + fast red tr salt is readily solubilized in dichloromethane and can be qunatified at 508nm.
- the aldehyde may be endogenous to the target molecule or may be induced chemically prior to subse ⁇ uent action with the enzyme hydrazide.
- amines can be derivatiz ⁇ d by dialdehydes as described below in formula 2b.
- vicinal hydroxyl groups on sugars can be oxidized to aldehydes upon chemical reaction with periodate. The same reaction is relatively specific for sialic acids when the reaction conditions (periodate concentration, temperature) are controlled.
- galactosyl residues can also be selectively oxidized to aldehydes by enzymatic treatment with galactose oxidase.
- the hydrazone group formed which links the enzyme to the target molecule can be further stabilized by reduction (e.g. borohydride or cyanoborohydride) as follows:
- oxidant e.g., permanganate amino-containing macromolecules (R-NH 2 )
- the following comprises a representative protocol for hydrazidation of an enzyme.
- Alkaline phosphatase is given here as a representative example.
- otner enzymes see list, section 2
- Binding protein mediators e.g. avidin
- Enzyme hydrazides can be prepared in numerous ways as detailed above in section 1). The preferred embodiment of the invention is described here; however, this particular approach toward preparation in no way limits the use of other hydrazidation strategies which we have outlined in section 1).
- Alkaline phosphatase 200 mg protein, 1.2 U/mg, Sigma Chem. Co.
- adipic dihydrazide 12.5 ml, brought to pH 4.5
- Water soluble carbodiimide (1-ethyl-3-(3-dimethylamino-propyl) carbodiimide, WSC, 0.8 g) is added.
- the pH is maintained between 4.5 and 5.5 by adding 1 N HCl.
- reaction mixture After 6 hr reaction at room temperature, the reaction mixture is maintained overnight at 4°C and then dialyzed against 0.9% (w/v) NaCl, and Tris buffer, pH 8.0 containing 1 mM MgCl 2 and 0.005% (w/v) NaN 3 .
- alkaline phosphatase (1200 U/mg) can be hydrazide modified using (per mg enzyme) 10 mg adipic dihydrazide and 2 to 10 mg WSA.
- the blot is then incubated in a 1-mM solution of sodium periodate 30 min at 4°C.
- the oxidized blot is briefly rinsed in PbS ano then incubated 2 hr at room temperature with alkaline phosphatase-hydrazide (15 units/ml diluted a thousand-fold with a solution of 1% BSA in 50 mM Tris-HCl pH 7.4).
- Enzyme hydrazides have oeen constructed for specific detection of glycoconjugates in cytochemical-microscopy, for gel electrophoretic analyses of glycoconjugates, for detection and analysis of glycoconjugates "blotted” onto nitrocellulose, nylon and other types of immobilizing matrices, etc. We have also indicated their suitability for the specific detection of macromolecules containing not only aldehydes out amines, hydroxyls, carboxyls, etc. (see section 3). Due to the fact that the enzyme hydrazides contain many hydrazide moieties per enzyme (or avidin or lectin or antibody; molecule, the system may be used to amplify the desired response or signal.
- the enzyme hydrazides can be employed in other less straightforward procedures.
- the described system can be used as a general protein stain. Since the enzyme hydrazide reacts specifically with aldehydes, glutaraldehyde fixed proteins react with this reagent as described in section 3.2.
- the sytem can be used for enzyme-conjugated immunoglobulins, i.e. the screening of monoclonal antibodies as well as immunocytochemical assays (e.g. ELISA) and various diagnostic kits which are based on coloriometric enzyme assays.
- immunoglobulins are themselves glycoproteins and susceptible to periodate oxidation without losing their activity
- enzyme hydrazides can easily be used for enzyme-conjugation of immunoglobulins.
- Glutaraldehyde-activated immunoglobulins can also interact with enzyme hydrazides for the preparation of conjugates.
- enzyme-hydrazides can be used to demonstrate those proteins which were on the cell surface (and thus susceptible to the periodate oxidation.
- the general approach here can also be used to immobilize proteins to solid supports or for crosslinking macromolecules or for preparing macromolecular conjugates.
- Membrane proteins from human erthrocyte ghosts separatee by SDS-PAGE, either stained directly with Coomassie Brilliant Blue (A) or PAS (B) or electrophoretically transferred to nitrocellulose memorane filters and stained for glycoconjugates using alkaline phosphatase-hydrazide (C).
- A Coomassie Brilliant Blue
- PAS PAS
- C alkaline phosphatase-hydrazide
Abstract
A hydrazide derivative of an enzyme wherein the hydrazine or hydrazide moiety is linked to the enzyme molecule either directly or via a functionally inert spacer, via a functionally active molecule or via an antibody directed to the specific enzyme. The hydrazine or polymeric form of hydrazide is preferably directly covalently linked to the enzyme, which linkage is advantageously via a functional group not effecting enzymatic activity selected from amino, carboxyl, aldehydo or sulfhydryl groups of the enzyme. There is further provided a method for the detection and determination of glycoconjugates for gel electrophoretic analysis of such glycoconjugates and the blots thereof, for the microscopic localization of such glycoconjugates, for the detection of macromolecules containing amino or aldehyde groups, carboxy or vicinal hydroxy groups, for the screening of monoclonal antibodies, which comprises interacting same with a hydrazido-enzyme conjugate according to claim 1, and utilizing the enzyme thereof for visualization or other detection and determination.
Description
ENZYME HYDRAZIDES FIELD OF THE INVENTION:
There are provided hydrazido derivatives of enzymes (enzyme hydrazides) for the selective staining or laoeling of various macromolecular species. Procedures involving the use of such enzyme hyαrazides may be rendereα specific chemically for proteins, glycoconjugates, sialoglycoconjugates, galactoglycoconjugates, nucleic acids, as well as naturally existing or chemically introduced carDonydrate-containing, aldehyde-containing, amino-containing, and carboxyl-containing macromolecules. The latter target compounds may be attached to solid supports, e.g. membrane filters, microtiter plates or intact cells, and the described procedures may be used for the detection, localization and quantification of the desired target compound.
BACKGROUND OF THE INVENTION:
The αetection, localization, identification ana assay of biologically active macromolecules are achieveα by a variety of analytical methods. The latter are usually accomplished by a comoination of physical-chemical separation together witn selective staining or labeling procedures. For example, a complex mixture of proteins can be separated according to size by polyacrylamide gel electrophoresis in the presence of sodium dodecyl suifate (SUS-PAGE) or according to charge by isoiectric focusing (IEF), and the pattern of the individual protein bands can oe visualized oy a general stain for proteins, e.g. Coomassie Brilliant Blue or Amido Black. Alernatively radiolaoled proteins may be visualized on gels by autoradiograpny.
Nucleic acids, resolved in agarose or in polyacrylamide gels, can be detected with Coomassie Brilliant Blue or via interaction with the fluorescent dye ethidium bromide.
Sugar-containing proteins (glycoproteins) and other sugar-containing macromolecules, e.g. glycolipids, mucopolysaccharides, lipopoly-saccharides, peptidoglycans, and simple homo- or heteropolysaccharides, can also be visualized by various techniques.
The phenomenal variety of biologically active carbohydrates is generated by the natural abundance of monosaccharide types, the range of possible glycosidic linkages between two sugars, and the two anomeric configurations. In contrast to this biological diversity, chemically the different types of sugars are very similar, since the hydroxyl group represents the major accessible chemcially reactive moiety. The availablility of chemical reactions which would be selective for labeling saccharide-containing macromolecules is therefore severely limited. In practice, only one enzymatic reaction
(i.e. the specific oxidation of D-galactose and
N-acetyl-D-galactosamine by the enzyme galactose oxidase, E.C. 1.1.3.9) and only one mild chemical reaction (i.e., periodate oxidation of vicinal hydroxyl groups) are currently in use to any great extent, both of which generate aldehyde groups on sugars. The resultant aldehydes can then be labeled specifically by chemical means.
One of the most prevalent techniαues for labeling oxidized sugars has been the formation of Schiff's bases with fuchsin (F.H. Kasten (1960) Int. Rev. Cytol. 10:1-100). Alternatively, the oxidized sugars can be labeled by radioactive reagents (e.g., tritiated sodium borohydride) and the latter can be visualized by autoradiography or radiofluorography.
Whereas in the past, characterization of resolved polypeptides in gels has been demonstrated (e.g. general staining of proteins with dyes such as Coomassie Brilliant Blue or of glycoproteins by periodic acid-Schiff stain (PAS), specific detection of glycoconjugates via
lectins or of antigens by antibodies, etc.), such methodologies are cumbersome and quite often inefficient. However, analysis of constituents of electrophoretograms has become more effective by the recent introduction of new and improved methooolgy by which macromolecules are first eluted from the gel and immobilized onto a suitable matrix prior to staining, a process termed "blotting" (J.M. Gershoni and G.E. Palade (1983) Anal. Biochem. 131:1-15). This procedure, has many inherent advantages, including (a) increased facility in handling, (b) improved accessibility of immobilized macromolecules to various reagents, (c) reduction in sample size, (d) reduction in processing time, (e) possibility for producing multiple replicas of single gels, (f) transferred patterns can be stored for long periods of time, (g) a single pattern can be subjected to multiple successive analyses, and (h) blots are amenable to analytical procedures impracticable on gels.
Due to the experimental facility afforded oy clotting procedures, much effort has been directed toward designing improved methods for general ano selective staining (or labeling) procedures applicable to this techniαue. Although general staining of proteins immobilized (biotted) onto nitrocellulose has been reported, the general staining of glycoconjugates has yet to be described.
SUMMARY OF THE INVENTION:
There is provided a novel type of staining or labeling process which is oased on the chemical interaction of enzyme hydrazides with a variety of target macromolecules. This process combines the chemical specificity and stability of the hydrazide moiety with the sensitivity and amplificatory properties of enzymes previously used in various
staining procedures and assays. The process can be used to stain aldehyde-containing, amino-containing or carboxyl-containing macromolecules and is suitable for blotting techniques, gels, solid-phase assay systems as well as for light and electron microscopic cytochemistry. 1. Preparation of enzyme hydrazides:
Enzyme hydrazides can be prepared in numerous ways. Several representative examples will oe described herein. Essentially, functional hydrazide residues or polymeric forms of hydrazides can be linked to a functional enzyme either (a) directly by chemical (covalent) means, (b) bridged via a functionally inert spacer, or (c) bridged via an intermediate functional molecules(s), e.g. via the avidin-biotin complex or via an antibody directed toward the enzyme. 1.1 Simple direct hydrazidation of endogenous enzyme carboxyls:
Hydrazides can be covalently linked to glutamate, aspartate and
C-terminal carboxyl residues of enzymes via interaction with hydrazine
(Ed. 1a) or dihyorazides (e.g. maleic, succinic or adipic dihydrazide;
Ed. 1b) in the presence of a water soluble carbodiimiαe (WSC), e.g. l-ethyl-3-(3-dimethylamino-propyl) carbodilmide.
(1.1a) ENZ-COOH + NH2NH2 ------------ ENZ-CONHNH2
WSC
(1.1b) ENZ-COOH + R-(CONHNH2)2 --------ENZ CONHNHCO-R-CONHNH2
WSC S
1.2 Simple direct hydrazidation via enzyme amino groups:
The enzyme can be reacted successively with an excess of dialdehyde (e.g. glutaraldehyde) followed by an excess of dihydrazide (i.e. maleic, succinic, adipic, etc.):
(1.2) ENZ-NH2 + R'-(CHO)2 --------> ENZ-N=CH-R'-CHO
ENZ-N=CH-R' -CH=N-NHCO-R-CONHNH2 Further stabilization of the hydrazone groupsformed can be accomplished by their reduction (e.g. using oorohydride, cyanoborohydride, etc.).
1.3 Simple direct hydrazidation of glycoproteins:
Hydrazide derivatives of glycoprotein enzymes or enzymes which have been glycosylated through chemical or enzymatic (or biological) means, can be prepared by prior activation of the resident sugars by periodate. Alternatively, enzymatic treatment, either by galactose oxidase alone or by combined neuraminidase/ galactose oxidase, will generate aldehydes on appropriate glycoproteins. The activated glycoprotein can then be incubated with a suitable dihydrazide thereby producing the enzyme hydrazide via endogenous carbohydrates.
(1.3) ENZ-(carbohydates) --------------------> ENZ-(carbohydrate)-CHO
ENZ-(carbohydrate)-CH=N-NH-R-CONHNH2
Again, the hydrazone group formed can be stabilized by reduction as described in section 1.2.
1.4 Hydrazidation of succinylated (carboxylated) enzyme:
The extent of hydrazidation of a given enzyme can be increased by first succinylating the resident amino groups of the enzyme followed by direct hydrazidation of both the endogenous (y) as well as the succinyl-derived (x) carboxyls on the modified enzyme.
(1.4) (HOOC)y-ENZ-(NH2)x + 2 O O CO
-----------> (HOOC)y-ENZ-[NHCO(CH2)2-COOH]x -------------------> (H2NHNOC)y-ENZ-(CONHNH2)x hydrazidation
1.5 Hydrazioation via enzyme-polyhyorazide conjugate:
A soluole polyhydrazide (e.g. polyacrylic hydrazide, polysialic acio hydrazide, or polyglutamic hyorazide) can oe conjugated(e.g. via glutaraldehyde or WSC) to the enzyme of choice.
(1.5) ENZ + P-(CONHNH2)x ---------> ENZ-P-(CONANH2)x
WSC or
R'-(CHO)2
1.6 Hydrazidation of enzyme-conjugated carooxyl-containing polymer:
In order to further increase the amount of hydrazide per enzyme, carboxyl containing polymers (e.g. polyglutamic acid) can also be conjugatedfirstto the enzyme and hydrazidation of the conjugate can then be performed.
(1.6) (HOOC)y-ENZ-NH2 + P-(COOH)x ------> (HOOC)y-ENZ-NHCO-P-(COOH)x
In cases where the enzyme is particularly sensitive to the chemical reactions described above (1.1-1.6), hydrazidation of an enzyme via a functional intermediate may be advantageous. Three examples of this approach are as follows:
Hydrazidation of an antibody which recognizes the enzyme can first oe performed and the antioody-hyαrazioe can be reacted with the target molecule. Suoseouently, the antiocoy-bound target molecule can be incubated with the unmodified enzyme. Alternatively, premade soluble complexes consisting of the enzyme and antibody-hydrazide can oe prepared and these complexes can be interacted with the target molecule.
(1.7a) ENZ + Ab-(CONHNH2)x -------> ENZ:Ab-(CONHNH )
Avidin-biotin technology can also serve as an appropriate intermediate. The enzyme can oe oiotinylateα unαer mild conditions which do not significantly affect enzyme activity (E.A. Bayer and M.
Wilchek (1980) Methods Biochem. Anal. 26:1-45). Likewise, avidin-hydrazide can be prepared by one of the above-described methods. The avidin-hydrazide can then oe used to chemically label the target molecule via the hyorazide moiety. Suoseαuent interaction with tne biotinylated enzyme serves to associate the enzyme ana target molecules via the avidin-biotin complex. Similar to antibody mediation, premade hydrazido-avioin/biotinylated enzyme complexes can be used to label the target molecule.
(1.7b) Biotin-ENZ + Avidin-(CONHNH2)x--->ENZ-Biotin:Avidin-(CONHNH2)x
In a similar manner, lectin-hydrazide can oe used to mediate between specific sugar moieties (eitner native or artificially introduced) which reside either on the target molecule and/or on the enzyme probe:
(1.7c) sugar-ENZ + Lectin-(CONHNH 2)x------> ENZ-sugar:Lectin-(CONHNH 2)x
2. Enzymes that can be hydrazide modified
In principle any enzyme can oe used for the preparation of the new reagent, the only constraint being that the process of adding the hydrazide functional group does not inactivate or interfere significantly with the enzyme activity. As hydrazide moieties may be introduced via many functional groups, e.g. via amino, carooxyl, aldehyoo or sulfhydryl groups, etc., of the protein, one would expect tnat a gentle permissible protocol for each possible enzyme to be modified could be developed.
If the enzyme hydrazide is to oe used for localization purposes via histochemical technioues, the product ootained snoulo be insoluble in aαueous solutions ano of a high contrast color. Numerous protocols of this type have been developed for a plethora of enzymes. References to a few examples are nerewith provided: (2a) Alkaline phosphatase; M.S. Burstone (1962) Enzyme Histochemistry and Its application in the study of Neoplasm. Academic Press,
NY. (2b) Acid phosphatase; M.S. Burstone (1961) J. Histochem. Cytochem.
9:146-153. (2c) 5' Nucleotidase; M. Wacnstein anc E. Meisel (1957) Am. J. Clin.
Pathol. 27:13-23.
(2d) Glucose 6-phosphatase; M. Wachstein and E. Meisel (1956) J.
Histochem. Cytochem. 4:592. (2e) Acetylcholine esterase; M.J. Karnovsky and L. Roots (1964) J.
Histochem. Cytochem. 12:219-221. (2f) β-Galactosidase; B.D. Lake (1974) Histochem. 0. 6:211-218. (2g) Dopa oxidase; B.Z. Rappaport (1955) Arch. Pathol. 60:444-450. (2h) Horseradish peroxidase; R.C. Graham and M.J. Karnovsky (1966) J. Histochem. Cytochem. 14:291-302. As is demonstrated from the above examples a variety of enzymes, i.e., phosphatases, oxido-reductases, hydrolases and esterases can be used. This, in addition to the numerous substrates that produce products of a wide spectrum of colors, allows the use of enzyme hydrazides in a multitude of conditions and provide the possibility of double labels which would be of particular importance in cytochemical analyses or diagnostic kits.
Quantitative detection of enzyme hydrazide conjugates is possible by reacting the enzyme with a substrate that renders a soluble product that can be quantified spectrophotometrically.
Thus o-phenyldiamine could be used for detection of horseradish peroxidase or p-nitrophenol phosphate for alkaline phosphatase or o-nitrophenyl galactoside with β-galactosidase, etc.
Another alternative which can provide quantitative detection is to solubilize the precipitated enzyme product in an organic solvent which can then be quantified spectrophotometrically. For example, the fast red product generated in the alkaline phosphatase reaction with napthol- AS-MX phosphate + fast red tr salt is readily solubilized in dichloromethane and can be qunatified at 508nm. 3. Target Macromolecules 3.1 Aldehyde-containing macromolecules
The chemistr involved in the interaction of aldeh des (RCHO) with
an enzyme hydrazide (ENZ-CONHNH2) is as follows:
(3.1a) RCHO + ENZ-CONHNH2 -------> R-CH=N-NHCO-ENZ
The aldehyde may be endogenous to the target molecule or may be induced chemically prior to subseαuent action with the enzyme hydrazide. For example, amines can be derivatizεd by dialdehydes as described below in formula 2b. In addition, vicinal hydroxyl groups on sugars can be oxidized to aldehydes upon chemical reaction with periodate. The same reaction is relatively specific for sialic acids when the reaction conditions (periodate concentration, temperature) are controlled. Furthermore galactosyl residues can also be selectively oxidized to aldehydes by enzymatic treatment with galactose oxidase. Thus, virtually any procedure by which a given target molecule can be selectively modified to contain aldehyde groups can be employed prior to interaction with an appropriate enzyme hydrazide.
As described in section 1.2, the hydrazone group formed which links the enzyme to the target molecule can be further stabilized by reduction (e.g. borohydride or cyanoborohydride) as follows:
(3.1b) RCH=N-NΗCO-ENZ -------> RCH2NHNHCO-ENZ
BH4
3.2 Amino-containing macromolecules
In the presence of a suitable oxidant, (e.g., permanganate) amino-containing macromolecules (R-NH2) will interact with hydrazides in the following manner:
(3.2a) R-NH2 + ENZ-CONHNH2 -------> R-NHCO-ENZ
KMnO4
An amino-containing macromolecuie can also oe converted to an alαenyde through the action of an excess of dialαehyoe as described in the following formula:
(3.2b) R-NH2 + OHC-(CH2)x-CHO --------> R-N=CH-(CH2)x-CHO
Attachment of the enzyme hydrazide is achieved by further treatment as descrioed aoove for aldehydes (section 3.1)
3.3 Carboxyl-containing macromolecules
In the presence of carbodiimide, carboxyl groups will interact with hydrazides as follows:
(3.3) R-COOH + ENZ-CONHNH2 -----------------> RCONHNHCO-ENZ
WSC Since most of the carboxyl moieties on the enzyme hydrazide have been converted to hydrazides, the carbodiimide would act selectively on the carooxyls of the target compounds. In this case the hyoraziαe functional group on the enzyme is exploited as a nucleophile.
EXPERIMENTAL DESCRIPTION
1. Preparation of Enzyme Hydrazides
The following comprises a representative protocol for hydrazidation of an enzyme. Alkaline phosphatase is given here as a representative example. We nave found that otner enzymes (see list, section 2) can oe modified under conditions in which enzymatic activity is preserved. Binding protein mediators (e.g. avidin) are also amenable to hydrazidation.
Enzyme hydrazides can be prepared in numerous ways as detailed above in section 1). The preferred embodiment of the invention is described here; however, this particular approach toward preparation in no way limits the use of other hydrazidation strategies which we have outlined in section 1).
Alkaline phosphatase (200 mg protein, 1.2 U/mg, Sigma Chem. Co.) is dissolved into a solution containing 1 g of adipic dihydrazide (12.5 ml, brought to pH 4.5). Water soluble carbodiimide (1-ethyl-3-(3-dimethylamino-propyl) carbodiimide, WSC, 0.8 g) is added. During the course of the reaction, the pH is maintained between 4.5 and 5.5 by adding 1 N HCl. After 6 hr reaction at room temperature, the reaction mixture is maintained overnight at 4°C and then dialyzed against 0.9% (w/v) NaCl, and Tris buffer, pH 8.0 containing 1 mM MgCl2 and 0.005% (w/v) NaN3.
In the same manner, highly purified alkaline phosphatase (1200 U/mg) can be hydrazide modified using (per mg enzyme) 10 mg adipic dihydrazide and 2 to 10 mg WSA. 2. Staining Immobilized Glycoproteins with Enzyme Hydrazides
(1) Run protein sample on a standard SDS-PAGE (U.K. Laemmli, Nature (London) 227:680-6851970).
(2) At the end of run, blot the gel to nitrocellulose membrane filter as previously described (J.M. Gershoni, and G.E. Palade, Anal. Biochem. 124:396-4071982).
(3) Quench blot with 2% bovine serum albumin (BSA) in phosphate-buffered saline, pH 7.4 (PBS) 2-12 hr at room temperature or 37°C.
(4) The blot is then incubated in a 1-mM solution of sodium periodate 30 min at 4°C.
(5) The oxidized blot is briefly rinsed in PbS ano then incubated 2 hr at room temperature with alkaline phosphatase-hydrazide (15 units/ml diluted a thousand-fold with a solution of 1% BSA in 50 mM Tris-HCl pH 7.4).
(6) The blot is thoroughly washed in PbS and then reacted with Napnthol As-Mx phosphate and Fast Red indol dye as described (H.Troyer (1980) Principles and Techniques of Histochemistry, Little, Brown and Co. Inc. Boston). Fast Violet, Fast Green or Fast Blue dyes may be substituted for Fast Reo in order to obtain the respective and desired color precipitate. The precipitate bands form at the areas containing immobilized sialoglycoproteins. In order to stain glycoproteins in general, high concentrations (> 25 mM) of periodate ano longer incubation times at different temperatures e.g. 1 hr at 25ºC) can be used. Fig. 1 demonstrates the labeling of erythrocyte membrane glycoproteins with alkaline phosphatase- hydrazide.
APPLICATIONS:
Enzyme hydrazides have oeen constructed for specific detection of glycoconjugates in cytochemical-microscopy, for gel electrophoretic analyses of glycoconjugates, for detection and analysis of glycoconjugates "blotted" onto nitrocellulose, nylon and other types of immobilizing matrices, etc. We have also indicated their suitability for the specific detection of macromolecules containing not only aldehydes out amines, hydroxyls, carboxyls, etc. (see section 3). Due to the fact that the enzyme hydrazides contain many hydrazide moieties per enzyme (or avidin or lectin or antibody; molecule, the system may be used to amplify the desired response or signal. Moreover, the enzyme hydrazides can be employed in other less straightforward procedures.
For example, the described system can be used as a general protein stain. Since the enzyme hydrazide reacts specifically with aldehydes, glutaraldehyde fixed proteins react with this reagent as described in section 3.2. In addition, the sytem can be used for enzyme-conjugated immunoglobulins, i.e. the screening of monoclonal antibodies as well as immunocytochemical assays (e.g. ELISA) and various diagnostic kits which are based on coloriometric enzyme assays. As immunoglobulins are themselves glycoproteins and susceptible to periodate oxidation without losing their activity, enzyme hydrazides can easily be used for enzyme-conjugation of immunoglobulins. Glutaraldehyde-activated immunoglobulins can also interact with enzyme hydrazides for the preparation of conjugates.
In cases where intact cells are oxidized with periodate and then subjected to gel electrophoresis and blotting, enzyme-hydrazides can be used to demonstrate those proteins which were on the cell surface (and thus susceptible to the periodate oxidation.
The general approach here can also be used to immobilize proteins to solid supports or for crosslinking macromolecules or for preparing macromolecular conjugates.
Legend to the Figure:
Membrane proteins from human erthrocyte ghosts, separatee by SDS-PAGE, either stained directly with Coomassie Brilliant Blue (A) or PAS (B) or electrophoretically transferred to nitrocellulose memorane filters and stained for glycoconjugates using alkaline phosphatase-hydrazide (C).
Claims
1. A hydrazide derivative of an enzyme wherein the hydrazine or hydrazide moiety is linked to the enzyme molecule either directly or via a functionally inert spacer, via a functionally active molecule or via an antibody directed to the specific enzyme.
2. A derivative according to claim 1, wherein the hydrazine or polymeric form of hydrazide is directly covalently linked to the enzyme.
3. A hydrazide derivative according to claim 1, wherein the hydrazide is linked to the enzyme via a functional group not affecting enzymatic activity selected from amino, carboxyl, aldehydo or sulfhydryl groups of the enzyme.
4. A hydrazide derivative according to claim 1, wherein there is used a hydrazine, or a dihydrazide (i.e. either H2NHNCONHNH2 or of the general formula H2NHNOC-(CH2)n-CONHNH2 where 0<n>12) in the presence of a water soluble carbodiimide forming an intermediate link.
5. A hydrazide derivative according to claim 1 wherein an enzyme is linked via an antibody to the hydrazido group, or where the enzyme is linked via the avidin-biotin complex or via lectin-sugar interactions to the hydrazido moiety.
6. A hydrazide according to claim 1 wherein the enzyme is selected from alkaline phosphatases, acid phosphatase, 5'-nucleotidase, glucose 6-phosphatase, acetylcholine esterase, β-galactosidase, dopa-oxidase, horseradish peroxidase.
7. A hydrazido derivative according to claim 1, wherein an enzyme-hydrazido conjugate is linked to an amino-containing macromolecuie, to an aldehyde containing macromolecuie, to a carboxyl containing macromolecuie forming respectively compounds of the general formulas R-NHCO-enz, R-CH=N-NHCO-enz, R-CH2NHNHCO-enz or R-CONHNH-enz wherein R is the residue of the macromolecuie.
8. A method for the detection and determination of glycoconjugates (either naturally occuring glycoconjugates or other macromolecules which have been glycosylated by chemical, biochemical or biological means) for gel electrophoretic analysis of such glycoconjugates and there blots thereof, for the microscopic localization of such glycoconjugates, for the detection of macromolecules containing amino or aldehyde groups, carboxy or vicinal hydroxy groups, for the screening of monoclonal antibodies, which comprises interacting same with a hydrazido-enzyme conjugate according to claim 1 and utilizing the enzyme thereof for visualization or other detection and determination.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL71947 | 1984-05-29 | ||
IL71947A IL71947A (en) | 1984-05-29 | 1984-05-29 | Enzyme hydrazides and method for detection and determination of glycoconjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1985005638A1 true WO1985005638A1 (en) | 1985-12-19 |
Family
ID=11055089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1985/000992 WO1985005638A1 (en) | 1984-05-29 | 1985-05-29 | Enzyme hydrazides |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0186692A4 (en) |
IL (1) | IL71947A (en) |
WO (1) | WO1985005638A1 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0230166A1 (en) * | 1985-11-25 | 1987-07-29 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Diagnostic reagents |
WO1990002136A1 (en) * | 1988-08-26 | 1990-03-08 | Robin Ewart Offord | Protein derivatives and a process for their preparation |
WO1991000296A1 (en) * | 1989-06-30 | 1991-01-10 | Board Of Regents Of The University Of Nebraska | Enzymatically binding bioactive materials to proteins |
EP0462669A2 (en) * | 1990-06-18 | 1991-12-27 | Johnson & Johnson Clinical Diagnostics, Inc. | Amine enriched proteins |
EP0563795A1 (en) * | 1992-03-31 | 1993-10-06 | Dai Nippon Printing Co., Ltd. | Enzyme-immobilized electrode, composition for preparation of the same and electrically conductive enzyme |
US6001364A (en) * | 1993-05-05 | 1999-12-14 | Gryphon Sciences | Hetero-polyoxime compounds and their preparation by parallel assembly |
US6174530B1 (en) | 1993-05-05 | 2001-01-16 | Gryphon Sciences | Homogeneous polyoxime compositions and their preparation by parallel assembly |
US6218160B1 (en) * | 1997-10-31 | 2001-04-17 | Roche Diagnostics Corporation | Site-specific conjugation of glycoproteins |
EP1257695A1 (en) * | 2000-01-11 | 2002-11-20 | Nanogen Recognomics GmbH | Biomolecules having multiple attachment moieties for binding to a substrate surface |
US6663869B1 (en) | 1993-05-05 | 2003-12-16 | Gryphon Therapeutics, Inc. | Polyoxime compounds and their preparation |
US7129229B2 (en) | 2000-08-11 | 2006-10-31 | Nanogen Recognomics Gmbh | Hydrazide building blocks and hydrazide modified biomolecules |
WO2009070640A2 (en) | 2007-11-28 | 2009-06-04 | Great Basin Scientific | Methods and compositions for amplifying a detectable signal |
EP2267030A1 (en) | 2005-08-25 | 2010-12-29 | Repair Technologies, Inc. | Devices, compositions and methods for the protection and repair of cells and tissues |
US8669236B2 (en) | 2005-05-12 | 2014-03-11 | The General Hospital Corporation | Biotinylated compositions |
CN104090095A (en) * | 2005-11-23 | 2014-10-08 | 文塔纳医疗系统公司 | Molecular conjugate |
EP3441467A2 (en) | 2012-08-31 | 2019-02-13 | The General Hospital Corporation | Biotin complexes for treatment and diagnosis of alzheimer's disease |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1223831A (en) * | 1982-06-23 | 1987-07-07 | Dean Engelhardt | Modified nucleotides, methods of preparing and utilizing and compositions containing the same |
-
1984
- 1984-05-29 IL IL71947A patent/IL71947A/en unknown
-
1985
- 1985-05-29 WO PCT/US1985/000992 patent/WO1985005638A1/en not_active Application Discontinuation
- 1985-05-29 EP EP19850903101 patent/EP0186692A4/en not_active Withdrawn
Non-Patent Citations (6)
Title |
---|
Biochemical and Biophysical Research Communications, 92(4), issued 1980, WILCHEK et al, "Fluorescent Reagents for the Labeling of Glycoconjugates in Solution and on Cell Surfaces", 1215-1222 * |
Biochemical and Biophysical Research Communications, 97(3), issued 1980, ROFFMAN et al, "Ferritin Hydrazide, A Novel Covalent Electron Dense Reagent for the Ultrastructural Localization of Glycoconjugates", 1192-1198. * |
CHEMICAL ABSTRACTS, 84: 40379w, issued 1976, CURTIS et al, "Fluorescent Water S oluble Carbodiimide-2-Hydroxy-3-Naphtoic Acid Hydrazide Reaction for the Demonstration of Carboxyl Groups in Protein and Mucosubstances", 190. * |
CHEMICAL ABSTRACTS, 89: 159737e, issued 1978, HENDERSON et al, "Specific Labeling of the Protein and Lipid on the Extracellular Surface of Purple Membrane", 263. * |
Immunoenzymatic Techniques, issued 1976, AVRAMEAS et al, American Elsevier Publishing Co., New York, 1-6 * |
See also references of EP0186692A4 * |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0230166A1 (en) * | 1985-11-25 | 1987-07-29 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Diagnostic reagents |
WO1990002136A1 (en) * | 1988-08-26 | 1990-03-08 | Robin Ewart Offord | Protein derivatives and a process for their preparation |
EP0359428A1 (en) * | 1988-08-26 | 1990-03-21 | Robin Ewart Offord | Protein derivatives and a process for their preparation |
US5741686A (en) * | 1989-06-30 | 1998-04-21 | Board Of Regents Of The University Of Nebraska | Exopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteins |
WO1991000296A1 (en) * | 1989-06-30 | 1991-01-10 | Board Of Regents Of The University Of Nebraska | Enzymatically binding bioactive materials to proteins |
US5279954A (en) * | 1989-06-30 | 1994-01-18 | Board Of Regents Of The University Of Nebraska And Bionebraska | Exopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteins |
EP0462669A2 (en) * | 1990-06-18 | 1991-12-27 | Johnson & Johnson Clinical Diagnostics, Inc. | Amine enriched proteins |
EP0462669A3 (en) * | 1990-06-18 | 1992-11-04 | Eastman Kodak Company | Amine enriched proteins |
EP0563795A1 (en) * | 1992-03-31 | 1993-10-06 | Dai Nippon Printing Co., Ltd. | Enzyme-immobilized electrode, composition for preparation of the same and electrically conductive enzyme |
US5804047A (en) * | 1992-03-31 | 1998-09-08 | Dai Nippon Printing Co., Ltd. | Enzyme-immobilized electrode, composition for preparation of the same and electrically conductive enzyme |
US6001364A (en) * | 1993-05-05 | 1999-12-14 | Gryphon Sciences | Hetero-polyoxime compounds and their preparation by parallel assembly |
US6174530B1 (en) | 1993-05-05 | 2001-01-16 | Gryphon Sciences | Homogeneous polyoxime compositions and their preparation by parallel assembly |
US6663869B1 (en) | 1993-05-05 | 2003-12-16 | Gryphon Therapeutics, Inc. | Polyoxime compounds and their preparation |
US6217873B1 (en) | 1993-05-05 | 2001-04-17 | Gryphon Sciences | Polyoxime compounds and their preparation |
US6218160B1 (en) * | 1997-10-31 | 2001-04-17 | Roche Diagnostics Corporation | Site-specific conjugation of glycoproteins |
EP1257695A1 (en) * | 2000-01-11 | 2002-11-20 | Nanogen Recognomics GmbH | Biomolecules having multiple attachment moieties for binding to a substrate surface |
EP1257695A4 (en) * | 2000-01-11 | 2005-03-02 | Nanogen Recognomics Gmbh | Biomolecules having multiple attachment moieties for binding to a substrate surface |
US7186813B1 (en) | 2000-01-11 | 2007-03-06 | Nanogen Recognomics Gmbh | Biomolecules having multiple attachment moieties for binding to a substrate surface |
US7129229B2 (en) | 2000-08-11 | 2006-10-31 | Nanogen Recognomics Gmbh | Hydrazide building blocks and hydrazide modified biomolecules |
US8669236B2 (en) | 2005-05-12 | 2014-03-11 | The General Hospital Corporation | Biotinylated compositions |
EP2267030A1 (en) | 2005-08-25 | 2010-12-29 | Repair Technologies, Inc. | Devices, compositions and methods for the protection and repair of cells and tissues |
CN104090095A (en) * | 2005-11-23 | 2014-10-08 | 文塔纳医疗系统公司 | Molecular conjugate |
US9310373B2 (en) | 2005-11-23 | 2016-04-12 | Ventana Medical Systems, Inc. | Molecular conjugate |
CN104090095B (en) * | 2005-11-23 | 2016-06-01 | 文塔纳医疗系统公司 | Molecular conjugate |
WO2009070640A2 (en) | 2007-11-28 | 2009-06-04 | Great Basin Scientific | Methods and compositions for amplifying a detectable signal |
EP3441467A2 (en) | 2012-08-31 | 2019-02-13 | The General Hospital Corporation | Biotin complexes for treatment and diagnosis of alzheimer's disease |
US10532104B2 (en) | 2012-08-31 | 2020-01-14 | The General Hospital Corporation | Biotin complexes for treatment and diagnosis of Alzheimer'S disease |
Also Published As
Publication number | Publication date |
---|---|
IL71947A0 (en) | 1984-09-30 |
EP0186692A4 (en) | 1988-11-22 |
IL71947A (en) | 1987-10-30 |
EP0186692A1 (en) | 1986-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1985005638A1 (en) | Enzyme hydrazides | |
Haselbeck et al. | Structural characterization of glycoprotein carbohydrate chains by using digoxigenin-labeled lectins on blots | |
JP5419993B2 (en) | Method and apparatus for immunoassay using nucleotide conjugates | |
Wilchek et al. | [35] Labeling glycoconjugates with hydrazide reagents | |
US7893253B2 (en) | Solid-phase oligosaccharide tagging: a technique for manipulation of immobilized carbohydrates | |
JP3524401B2 (en) | Enzyme-antibody complex and method for producing the same | |
GB1570532A (en) | Reagent suitable for enzyme immuno assay | |
Bendayan | A review of the potential and versatility of colloidal gold cytochemical labeling for molecular morphology | |
Gabius et al. | Neoglycoenzymes: a versatile tool for lectin detection in solid-phase assays and glycohistochemistry | |
DE19818360C2 (en) | Dextran coated surface | |
EP1448991A2 (en) | Activated enzyme-linked detection systems for detecting and quantifying nucleid acids, antigens, antibodies and other analytes | |
Haselbeck et al. | Immunological detection of glycoproteins on blots based on labeling with digoxigenin | |
Lee et al. | Efficient coupling of glycopeptides to proteins with a heterobifunctional reagent | |
US20020110846A1 (en) | Amplified array analysis method and system | |
Bayer et al. | [12] The ultrastructural visualization of cell surface glycoconjugates | |
DE602004007779T2 (en) | ENTGLYCOSILIZED ENZYMES FOR CONJUGATES | |
US6027874A (en) | Immunoenzymatic conjugate, method for its productions, applications thereof | |
Etxebarria et al. | Three‐Dimensional Arrays Using GlycoPEG Tags: Glycan Synthesis, Purification and Immobilisation | |
DE19732917C1 (en) | Coupling of protein or peptide, e.g. enzyme, to carrier | |
Másson et al. | Chemical activation of nitrocellulose membranes for peptide antigen‐antibody binding studies: direct substitution of the nitrate group with diaminoalkane | |
CN112305227A (en) | Self-crosslinking proteins, ligand compositions, methods of preparation, kits and systems | |
Hersh et al. | Preparation, characterization, and use of an antiserum specific for 2 ‘, 5 ‘-oligoadenylates. | |
US8153367B2 (en) | Amplified array analysis system | |
KR101101375B1 (en) | Immobilization method of carbohydrates | |
US20220106621A1 (en) | System and method for detecting a target enzyme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1985903101 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1985903101 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1985903101 Country of ref document: EP |